The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results